Eagle Health Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15M | Sell |
46,086
-19,570
| -30% | -$6.38M | 3.71% | 12 |
|
|
2025
Q1 | $17.7M | Sell |
65,656
-10,600
| -14% | -$2.86M | 4.6% | 10 |
|
|
2024
Q4 | $17.9M | Hold |
76,256
| – | – | 4.4% | 12 |
|
|
2024
Q3 | $21M | Hold |
76,256
| – | – | 3.97% | 12 |
|
|
2024
Q2 | $18.5M | Buy |
76,256
+27,900
| +58% | +$6.78M | 3.25% | 14 |
|
|
2024
Q1 | $7.23M | Sell |
48,356
-88,400
| -65% | -$13.2M | 1.34% | 21 |
|
|
2023
Q4 | $26.2M | Hold |
136,756
| – | – | 5.32% | 9 |
|
|
2023
Q3 | $24.2M | Hold |
136,756
| – | – | 5.34% | 9 |
|
|
2023
Q2 | $26M | Hold |
136,756
| – | – | 4.86% | 9 |
|
|
2023
Q1 | $27.4M | Sell |
136,756
-18,960
| -12% | -$3.8M | 5.33% | 8 |
|
|
2022
Q4 | $37M | Sell |
155,716
-6,000
| -4% | -$1.43M | 8.54% | 2 |
|
|
2022
Q3 | $32.4M | Buy |
161,716
+12,336
| +8% | +$2.47M | 7.43% | 3 |
|
|
2022
Q2 | $21.8M | Buy |
149,380
+18,136
| +14% | +$2.65M | 5.08% | 8 |
|
|
2022
Q1 | $21.4M | Buy |
131,244
+17,542
| +15% | +$2.86M | 5.28% | 8 |
|
|
2021
Q4 | $19.3M | Buy |
113,702
+23,600
| +26% | +$4M | 4.7% | 9 |
|
|
2021
Q3 | $17M | Sell |
90,102
-18,077
| -17% | -$3.41M | 5.4% | 7 |
|
|
2021
Q2 | $18.3M | Hold |
108,179
| – | – | 6.29% | 5 |
|
|
2021
Q1 | $15.3M | Buy |
108,179
+22,386
| +26% | +$3.16M | 6% | 8 |
|
|
2020
Q4 | $11.2M | Buy |
+85,793
| New | +$11.2M | 7.13% | 6 |
|